These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


783 related items for PubMed ID: 10212103

  • 1. Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma.
    van Rensen EL, Straathof KC, Veselic-Charvat MA, Zwinderman AH, Bel EH, Sterk PJ.
    Thorax; 1999 May; 54(5):403-8. PubMed ID: 10212103
    [Abstract] [Full Text] [Related]

  • 2. Protective effects of fluticasone on allergen-induced airway responses and sputum inflammatory markers.
    Parameswaran K, Inman MD, Watson RM, Morris MM, Efthimiadis A, Ventresca PG, Lam R, O'Byrne PM, Hargreave FE.
    Can Respir J; 2000 May; 7(4):313-9. PubMed ID: 10980457
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma.
    Jatakanon A, Lim S, Kharitonov SA, Chung KF, Barnes PJ.
    Thorax; 1998 Feb; 53(2):91-5. PubMed ID: 9624291
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Montelukast versus fluticasone: effects on lung function, airway responsiveness and inflammation in moderate asthma.
    Kanniess F, Richter K, Böhme S, Jörres RA, Magnussen H.
    Eur Respir J; 2002 Oct; 20(4):853-8. PubMed ID: 12412675
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of low dose fluticasone/salmeterol combination on surrogate inflammatory markers in moderate persistent asthma.
    Currie GP, Syme-Grant NJ, McFarlane LC, Carey FA, Lipworth BJ.
    Allergy; 2003 Jul; 58(7):602-7. PubMed ID: 12823118
    [Abstract] [Full Text] [Related]

  • 18. Alterations in airway inflammation and lung function during corticosteroid therapy for atopic asthma.
    Faul JL, Demers EA, Burke CM, Poulter LW.
    Chest; 2002 May; 121(5):1414-20. PubMed ID: 12006422
    [Abstract] [Full Text] [Related]

  • 19. Baseline airway hyperresponsiveness and its reversible component: role of airway inflammation and airway calibre.
    Ichinose M, Takahashi T, Sugiura H, Endoh N, Miura M, Mashito Y, Shirato K.
    Eur Respir J; 2000 Feb; 15(2):248-53. PubMed ID: 10706487
    [Abstract] [Full Text] [Related]

  • 20. Induced sputum and bronchoalveolar lavage as tools for evaluating the effects of inhaled corticosteroids in patients with asthma.
    Nocker RE, Out TA, Weller FR, de Riemer MJ, Jansen HM, van der Zee JS.
    J Lab Clin Med; 2000 Jul; 136(1):39-49. PubMed ID: 10882226
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 40.